BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33302608)

  • 1. Cannabinoids in Glaucoma Patients: The Never-Ending Story.
    Passani A; Posarelli C; Sframeli AT; Perciballi L; Pellegrini M; Guidi G; Figus M
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33302608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Cannabinoids in Glaucoma.
    Lindner T; Schmidl D; Peschorn L; Pai V; Popa-Cherecheanu A; Chua J; Schmetterer L; Garhöfer G
    Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The arguments for and against cannabinoids application in glaucomatous retinopathy.
    Panahi Y; Manayi A; Nikan M; Vazirian M
    Biomed Pharmacother; 2017 Feb; 86():620-627. PubMed ID: 28027538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids in the treatment of glaucoma.
    Järvinen T; Pate DW; Laine K
    Pharmacol Ther; 2002 Aug; 95(2):203-20. PubMed ID: 12182967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease.
    Kokona D; Georgiou PC; Kounenidakis M; Kiagiadaki F; Thermos K
    Neural Plast; 2016; 2016():8373020. PubMed ID: 26881135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.
    ElSohly MA; Harland EC; Benigni DA; Waller CW
    Curr Eye Res; 1984 Jun; 3(6):841-50. PubMed ID: 6329602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marijuana smoking vs cannabinoids for glaucoma therapy.
    Green K
    Arch Ophthalmol; 1998 Nov; 116(11):1433-7. PubMed ID: 9823341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids for treatment of glaucoma.
    Novack GD
    Curr Opin Ophthalmol; 2016 Mar; 27(2):146-50. PubMed ID: 26840343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft cannabinoid analogues as potential anti-glaucoma agents.
    Buchwald A; Browne CE; Wu WM; Ji F; Bodor N
    Pharmazie; 2000 Mar; 55(3):196-201. PubMed ID: 10756540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice.
    Millar JC; Savinainen A; Josiah S; Pang IH
    Exp Eye Res; 2019 Nov; 188():107763. PubMed ID: 31421135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice.
    Holló G; Topouzis F; Fechtner RD
    Expert Opin Pharmacother; 2014 Aug; 15(12):1737-47. PubMed ID: 24998246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma.
    Jayanetti V; Sandhu S; Lusthaus JA
    J Exp Pharmacol; 2020; 12():539-548. PubMed ID: 33244278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soft cannabinoid analogues as potential anti-glaucoma agents.
    Buchwald A; Derendorf H; Ji F; Nagaraja NY; Wu WM; Bodor N
    Pharmazie; 2002 Feb; 57(2):108-14. PubMed ID: 11878185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication.
    King AJ; Rotchford AP
    JAMA Ophthalmol; 2016 Jul; 134(7):742-7. PubMed ID: 27148831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma.
    Lusthaus JA; Goldberg I
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1201-8. PubMed ID: 27548834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
    Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
    Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities of applying cannabinoids' in the treatment of glaucoma].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(7-9):314-7. PubMed ID: 19112869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marijuana for Glaucoma: A Recipe for Disaster or Treatment?
    Sun X; Xu CS; Chadha N; Chen A; Liu J
    Yale J Biol Med; 2015 Sep; 88(3):265-9. PubMed ID: 26339209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
    Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
    J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.